If you have trouble viewing this page please try installing one of the browsers below:
East Jefferson General Hospital has entered into an agreement with Tulane University Medical Group to provide neurosurgical services, including enhanced cranial and spinal care at its Metairie campus.
The practice includes the following physicians:
This new relationship gives all EJGH patients access to the highest standard of care in neurosurgery," notes Mark J. Peters, MD, President and Chief Executive Officer of the community hospital. "This group of physicians brings with them the clinical expertise required for complex endovascular care, aneurysm treatments, and embolization procedures. Previously, these cutting edge skill sets were not available at East Jefferson. It's a great day for neurosurgical care – new treatments and procedures will be available to all of our patients."
The neurosurgery group has a clinic on the East Jefferson campus, located at 4224 Houma Boulevard, Suite 550. The practice accepts all major insurance plans, as well as Medicare and Medicaid. For an appointment, call the practice at 504-503-7001 or call HealthFinder at 504-456-5000.
East Jefferson General Hospital and Wound Care Specialists are proud to announce the opening of the new East Jefferson Wound and Hyperbaric Medicine Center. Hyperbaric oxygen therapy will operate in conjunction with East Jefferson’s existing wound care center which already provides outpatient services to people with chronic or difficult to heal wounds. Hyperbaric medicine, also known as hyperbaric oxygen therapy (HBOT), is the medical use of concentrated oxygen at levels higher than atmospheric pressure. HBOT has numerous indications some of which include the treatment of certain diabetic wounds of the lower extremities, necrotizing soft tissue infections, chronic refractory osteomyelitis, radiation necrosis, and failed skin grafts.
The goal of the East Jefferson Wound and Hyperbaric Medicine Center is to significantly increase patients’ wound healing rates and improve patients’ quality of life.
Prostate cancer is one of the most common cancers in American men. Genetics and age play a role in its development. But what other risks are involved? Below you will find information including frequently asked questions about prostate cancer along with information on screening and treatments for prostate cancer. EJGH is recognized as the region's only member of the MD Anderson Cancer Network, that affiliation, which gives our member physicians access to the exact treatments and pathways used at MD Anderson Cancer Center in Houston Texas, gives our patients not only greater hope, but also the highest levels of care possible in our region. Below you will see how EJGH has innovated the biopsy and treatment methods associated with this cancer. If you, or someone you know, needs to consult with a physician regarding your prostate health, contact HealthFinder at 504-456-5000. They will be happy to connect you with a physician who meets your health and insurance needs.
What is Prostate Cancer?
Prostate cancer is the most common cancer in American men, and in most men it grows very slowly. There are often no early prostate cancer symptoms. Prostate cancer treatment includes surgery, chemotherapy, cryotherapy, hormonal therapy, and/or radiation. In some instances, doctors recommend "watchful waiting."
What Causes Prostate Cancer?
Diet and genetics may be factors in prostate cancer development, but they are not the only ones. Research shows that our lifestyle choices factor in as well. Drinking, smoking and other choices can significantly heighten your risk factors. Age, race and family history, even a sedentary lifestyle can play a factor as well.
How Can I Prevent Prostate Cancer?
It may not be possible to prevent prostate cancer, but you may be able to lower your risk. Taking Vitamin E, moving to a leaner diet high in fruits and vegetables, eliminating tobacco, minimizing your alcohol intake, exercising regularly and managing stress can all be beneficial in prevention/risk reduction.
Is Prostate Cancer Screening Necessary?
Despite controversy, most doctors agree the prostate-specific antigen (PSA) blood test remains an important and necessary diagnostic tool. Men over 50 should absolutely add a prostate screening to their annual exam regimen.
Some screening tests are used because they have been shown to be helpful both in finding cancers early and decreasing the chance of dying from these cancers. Other tests are used because they have been shown to find cancer in some people; however, it has not been proven in clinical trials that use of these tests will decrease the risk of dying from cancer.
Scientists study screening tests to find those with the fewest risks and most benefits. Cancer screening trials also are meant to show whether early detection (finding cancer before it causes symptoms) decreases a person's chance of dying from the disease. For some types of cancer, finding and treating the disease at an early stage may result in a better chance of recovery.
There is no standard or routine screening test for prostate cancer.
Screening tests for prostate cancer are under study, and there are screening clinical trials taking place in many parts of the country. Information about ongoing clinical trials is available from the National Cancer Instiute at www.cancer.gov
Tests to detect prostate cancer that are being studied include the following:
East Jefferson General Hospital has a tremendous track record in the treatment of prostate cancer. In fact, prostate cancer was one of the four cancers, along with breast, lung and blood cancers such as leukemia that EJGH first focused on in earning affiliation as a member of the MD Anderson Cancer Network. To that end, EJGH has been a leader in bringing the very latest techniques, technologies and talent to bare in the fight against prostate cancer. From Radiation to Hormone Treatment to Robotic Surgery, EJGH has been an innovative, AND EFFECTIVE fighter against prostate cancer.
EJGH is proud to introduce a powerful new solution for targeted biopsy of the prostate. The UroNav fusion biopsy system offers a cutting edge option for many patients with elevated and/or rising PSA levels. UroNav fuses pre-biopsy MR images of the prostate with ultrasound-guided biopsy images in real time, for excellent delineation of the prostate and suspicious lesions.
Targeted MR/ultrasound biopsy is poised to become the new standard in prostate care, and EJGH is pleased to offer this powerful solution to our patients.
CLICK HERE to learn more about UroNav.
With the addition of the S-Generation da Vinci Robotic Surgical System, East Jefferson General Hospital stands at the fore in the areas of robotic and minimally invasive surgery. Traditional prostate surgery calls for an incision running from the navel to the groin. The surgery is usually followed by several days of hospitalization and a recovery period that can take weeks.
Today, da Vinci represents the gold standard in prostatectomy. Robotic Prostatectomy allows for three incisions that are each less than an inch long. Patients are usually hospitalized a couple of days and recovery times are reduced by several days.
CLICK HERE to learn more about the da Vinci Robotic Surgical System at EJGH.
EJGH is one of the first hospitals in Louisiana to offer 3D Mammography. This new state-of-the-art technology provides 3-dimensional images of the breast, which can help detect abnormalities in dense breast better than standard mammography.
Shawn Hotard, a wife and mother in her mid-forties, faces a diagnosis no woman wants to hear – breast cancer. Shawn is also an EJGH team member and radiology tech who understands the clinical benefits of catching cancer early. That is why she followed her physician's advice to have frequent mammogram screenings due to her dense breast tissue, even though she had no family history of the disease. And, that decision may have saved her life.
Conventional mammograms may have missed her cancer because it does not always offer a clear enough image through dense breast tissue. Now, with the use of 3D mammography technology, EJGH radiologists can detect cancers and better differentiate between cancers and normal breast cysts.
Shawn is now undergoing chemotherapy and will have radiation therapy as part of her future regimens of treatment.
CLICK HERE to view a WWL-TV story that features Shawn Hotard and EJGH Radiologist Dr. Mary Beth Lobrano.
CLICK HERE to learn more about The Breast Care Center at EJGH and 3D mammography.